proE-cad670-Luc Citations (4)
Originally described in: E-cadherin is transcriptionally activated via suppression of ZEB1 transcriptional repressor by small RNA-mediated gene silencing.Mazda M, Nishi K, Naito Y, Ui-Tei K PLoS One. 2011;6(12):e28688. doi: 10.1371/journal.pone.0028688. Epub 2011 Dec 21. PubMed Journal
Articles Citing proE-cad670-Luc
Articles |
---|
Unravelling the transcriptional responses of TGF-beta: Smad3 and EZH2 constitute a regulatory switch that controls neuroretinal epithelial cell fate specification. Andrews D, Oliviero G, De Chiara L, Watson A, Rochford E, Wynne K, Kennedy C, Clerkin S, Doyle B, Godson C, Connell P, O'Brien C, Cagney G, Crean J. FASEB J. 2019 May;33(5):6667-6681. doi: 10.1096/fj.201800566RR. Epub 2019 Feb 19. PubMed |
Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation. Al-Marsoummi S, Vomhof-DeKrey E, Basson MD. Cell Physiol Biochem. 2019;53(6):999-1014. doi: 10.33594/000000191. PubMed |
Cooperative interaction between ERalpha and the EMT-inducer ZEB1 reprograms breast cancer cells for bone metastasis. Mohammadi Ghahhari N, Sznurkowska MK, Hulo N, Bernasconi L, Aceto N, Picard D. Nat Commun. 2022 Apr 19;13(1):2104. doi: 10.1038/s41467-022-29723-5. PubMed |
Effects of Red Sorghum-Derived Deoxyanthocyanidins and Their O-beta-D-Glucosides on E-Cadherin Promoter Activity in PC-3 Prostate Cancer Cells. Mora N, Rosa M, Touaibia M, Martin LJ. Molecules. 2024 Apr 21;29(8):1891. doi: 10.3390/molecules29081891. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.